JS Bio and Etta Biotech Advancing Strategic Partnership
Share: Jianshun Biosciences Co., Ltd. ("JS Bio") recently announced its strategic partnership with Etta Biotech Co., Ltd. ("Etta Biotech"), to set up a high titer transient protein expression platform for high quality protein production using JS Bio's transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech's transient transfection high titer protein expression platform. Dr. Edward Dai, Chairman and CEO of Etta Biotech (left); Dr. Luo Shun, Chairman and President of JS Bio (right) (Photo: Business Wire) Etta Biotech is a leading cell electroporation te...
Source: benzinga.com